Edition:
United States

Axsome Therapeutics Inc (AXSM.OQ)

AXSM.OQ on NASDAQ Stock Exchange Global Market

2.55USD
4:00pm EDT
Change (% chg)

$-0.05 (-1.92%)
Prev Close
$2.60
Open
$2.60
Day's High
$2.65
Day's Low
$2.55
Volume
17,275
Avg. Vol
56,384
52-wk High
$6.45
52-wk Low
$2.05

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.306
Sep '17 0.00 -0.272
Jun '17 0.00 -0.300
Mar '17 0.00 -0.409
FY 2016 Dec '16 0.00 -0.383
Sep '16 0.00 -0.376
Jun '16 0.00 -0.356
Mar '16 0.00 -0.306
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-18 2 10.00 20.00 0.00 16.87
Year Ending Dec-19 2 12.50 25.00 0.00 20.56
Earnings (per share)
Quarter Ending Jun-18 2 -0.25 -0.23 -0.27 -0.70
Quarter Ending Sep-18 2 -0.25 -0.24 -0.27 -0.79
Year Ending Dec-18 2 -0.67 -0.26 -1.08 -2.03
Year Ending Dec-19 2 -1.33 -0.85 -1.80 -2.72
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 200.91 33.50
P/E High - Last 5 Yrs. -- 289.20 46.07
P/E Low - Last 5 Yrs. -- 96.91 24.95
Beta -- 0.75 0.80
Price to Sales (TTM) -- 139.09 7.25
Price to Book (MRQ) 3.96 20.64 5.09
Price to Tangible Book (MRQ) 3.96 25.50 6.62
Price to Cash Flow (TTM) -- 130.26 25.50
% Owned Institutions 28.40 11.26 2.24

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.53
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.97 3.92
Payout Ratio(TTM) -- 9.05 20.54

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 81.71 8.68
Sales (TTM) vs TTM 1 Yr. Ago -- 96.34 11.19
Sales - 5 Yr. Growth Rate -- 34.26 8.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 19.90 -64.57 22.73
EPS (TTM) vs TTM 1 Yr. Ago 9.31 -- --
EPS - 5 Yr. Growth Rate -- 48.47 10.28
Capital Spending - 5 Yr. Growth Rate -- 45.82 10.41

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.61 2.53
Current Ratio (MRQ) 2.90 6.04 3.61
LT Debt to Equity (MRQ) 39.86 23.33 11.39
Total Debt to Equity (MRQ) 59.41 25.72 14.02
Interest Coverage (TTM) -207.99 -190.60 39.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 35.01 54.05
Gross Margin - 5 Yr. Avg. -- 55.51 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -150.51 15.90
Operating Margin (TTM) -- -562.45 4.09
Operating Margin - 5 Yr. Avg. -- -162.33 11.23
Pre-Tax Margin (TTM) -- -534.74 4.81
Pre-Tax Margin - 5 Yr. Avg. -- -168.92 11.54
Net Profit Margin (TTM) -- -524.03 1.42
Net Profit Margin - 5 Yr. Avg. -- -168.92 7.87
Effective Tax Rate (TTM) -- -0.15 30.96
Effective Tax Rate - 5 Yr. Avg. -- 18.29 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,331,705 813,295,447
Net Income/Employee (TTM) -1,157,736 1,121,504 95,590,786
Receivable Turnover (TTM) -- 6.53 5.56
Inventory Turnover (TTM) -- 2.32 3.44
Asset Turnover (TTM) 0.00 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -78.47 -0.74 10.51
Return on Assets - 5 Yr. Avg. -- 0.80 11.54
Return on Investment (TTM) -106.37 -0.75 13.17
Return on Investment - 5 Yr. Avg. -- 4.16 14.94
Return on Equity (TTM) -151.19 -2.86 14.98
Return on Equity - 5 Yr. Avg. -- -0.19 16.23
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 10.49 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Axsome Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.70 -3.59 96 23
13 Week -11.86 -8.81 80 82
26 Week -49.02 -51.79 20 90
52 Week -27.78 -37.55 66 80
YTD -53.57 -54.17 10 91
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 28.40%
# of Holders: 44
Total Shares Held: 7,241,150
3 Mo. Net Change: 25
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.